Difference between revisions of "Team:Yale/collaborations"

Line 68: Line 68:
 
       <p class="text-center"><a href="https://static.igem.org/mediawiki/2015/c/cb/2015_Yale_iGEM_Collaboration.pdf" class="file__link">2015 Non-Model Organism Handout</a></p>
 
       <p class="text-center"><a href="https://static.igem.org/mediawiki/2015/c/cb/2015_Yale_iGEM_Collaboration.pdf" class="file__link">2015 Non-Model Organism Handout</a></p>
 
     </section>
 
     </section>
−
    <section class="content__section">
+
 
−
      <h2 id="protocat">ProtoCat - <a href="#" target="_blank" class="uni__link">University of Michigan</a></h2>
+
−
      <h3>A Centralized, Validated Protocols Database</h3>
+
−
      <div class="readable">
+
−
        <p>Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L-3,5-dihydroxyphenylalanine (L-DOPA), a nonstandard amino acid that was incorporated using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels.</p>
+
−
        <p>Biofilm formation on surfaces is an issue in the medical field, naval industry, and other areas. We developed an anti-fouling peptide with two modular components: a mussel adhesion protein (MAP) anchor and LL-37, an antimicrobial peptide. MAPs can selectively attach to metal and organic surfaces via L-3,5-dihydroxyphenylalanine (L-DOPA), a nonstandard amino acid that was incorporated using a genetically recoded organism (GRO). Because this peptide is toxic to the GRO in which it is produced, we designed a better controlled inducible system that limits basal expression. This was achieved through a novel T7 riboregulation system that controls expression at both the transcriptional and translational levels.</p>
+
−
      </div>
+
−
    </section>
+
−
 
+
 
     <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
 
     <script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
 
     <script src="assets/js/app.min.js"></script>
 
     <script src="assets/js/app.min.js"></script>

Revision as of 03:12, 17 September 2015


<!DOCTYPE html> Yale iGem 2015: Collaborations

Collaborations

Featuring University of La Verne!

Guidebook

Developing a Guidebook - University of La Verne iGEM

Beginning Research in Non-Model Microbes

Over the past few years, iGEM has increasingly centered around non-model microorganisms—organisms which are less well-characterized and have fewer resources for genetic manipulation than the model E. coli and S. cerevisiae. Despite a prevalence of non-model organisms in iGEM competition projects and the potential impact which these projects may have, few resources exist for teams hoping to initiate research in non-model strains.

The 2015 Yale University iGEM team has collaborated with several other teams working in non-model strains to design a set of considerations for future iGEM teams in order to reduce the barrier to entry into non-model organisms. We synthesized the experiences of other teams into a handout, which has been made available on our team wiki and will be available at out poster at the Jamboree.

2015 Non-Model Organism Handout

Yale iGEM 2015

Main Campus:

Yale Department of Molecular, Cellular & Developmental Biology

Attn: Farren Isaacs/iGEM

219 Prospect St

PO Box 208103

New Haven, CT 06520

Tel. +1(203) 432-3783

E-mail: igem.yale@gmail.com

© Yale iGEM 2015